Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: A double-blind, placebo-controlled, randomized trial

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 5 II, 1999, Pages 810-815

  Salmun, Luis M ^a   Barlan, Isil ^b   Wolf, Hermann M ^c   Eibl, Martha ^c   Twarog, Frank J ^a   Geha, Raif S ^a   Schneider, Lynda C ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Asthma; Intravenous immunoglobulin; Steroids

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN; IPRATROPIUM BROMIDE; STEROID; THEOPHYLLINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; IMMUNOMODULATION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ASTHMA; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; STEROIDS;

EID: 0033057149     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70424-0     Document Type: Article

References (33)

1. Kaliner M. Asthma deaths. A social or medical problem? JAMA 1993;269:1994-5.
2. Taylor R, Newacheck P. Impact of childhood asthma on health. Pediatrics 1992;90:657-62.
3. Friday G, Fireman P. Morbidity and mortality of asthma. Pediatr Clin North Am 1988;35:1149-62.
4. Ballow M. Mechanisms of action of intravenous immune serum globulin therapy. Pediatr Infect Dis J 1994;13:806-11.
5. Stiehm ER. Recent progress in the use of intravenous immunoglobulin. Curr Probl Pediatr 1992;22:335-48.
6. Debre M, Bonnet MC, Fridman WH, et al. Infusion of Fc γ fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 1993;342:945-9.
7. Imbach P, Barandun S, d'Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228-31.
8. Bernatowska ME, Pac M, Skopcynska H, Pum M, Eibl MM. Clinical efficacy of intravenous immunoglobulin in patients with severe inflammatory chest disease and IgG3 subclass deficiency. Clin Exp Immunol 1991;85:193-7.
9. Mazer B, Gelfand E. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol 1991;87:976-83.
10. Medical Section of the American Lung Association. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
11. Cross D, Nelson H. The role of the peak flow meter in the diagnosis and management of asthma. J Allergy Clin Immunol 1991;87:120-8.
12. Mazer BD, Giclas PC, Gelfand EW. Immunomodulatory effects of intravenous immunoglobulin in severe steroid-dependent asthma. Clin Immunol Immunopathol 1989;53:S156-63.
13. Jakobsson T, Croner S, Kjellman NIM, Pettersson A, Vassella C, Bjorksten B. Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma. Allergy 1994;49:413-20.
14. Jeffrey P, Wardlaw A, Nelson F, et al. Bronchial biopsies in asthma. Am Rev Respir Dis 1989;140:1745-53.
15. Beasley R, Roche W, Roberts J, et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
16. Fanta C, Rossing T, McFadden E. Glucocorticoids in acute asthma. Am J Med 1983;74:845-51.
17. Barnes P. A new approach to the treatment of asthma. N Engl J Med 1989;321:1517-27.
18. Marini M, Avoni E, Hollemborg J, et al. Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from non atopic patients with symptomatic asthma. Chest 1992;102:661-9.
19. Adelroth E, Rosenhall L, Johansson S, et al. Inflammatory cells and eosinophilic activity in asthmatics investigated by BAL. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 1990;142:91-9.
20. Diaz P, Gonzalez M, Galleguillos F, et al. Leukocytes and mediators in BAL during allergen-induced late-phase asthmatic reactions. Am Rev Respir Dis 1989;139:1383-9.
21. Corrigan C, Hartnell A, Kay A. T-lymphocyte activation in acute severe asthma. Lancet 1988;1:1129-32.
22. Corrigan C, Kay A. CD-4 T-lymphocyte activation in acute severe asthma. Am Rev Respir Dis 1990;141:970-7.
23. Azzawi M, Bradley B, Jeffrey P, et al. Identification of activated T-lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990;142:1407-13.
24. Robinson D, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
25. Robinson D, Hamid Q, Ying S, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell IL-4, IL-5 and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993;148:401-6.
26. Wegner CD, Gundel RH, Reilly P, et al. Intercellular adhesion molecule-1 in the pathogenesis of asthma. Science 1990;247:456-9.
27. Vignola AM, Campbell AM, Chanez P, et al. HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 1993;148:689-94.
28. Newburger J, Takahashi M, Beiser A, et al. A single intravenous infusion of gammaglobulin as compared with four infusions in the treatment of acute Kawasaki Syndrome. N Engl J Med 1991;324:1633-9.
29. Leung D. The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases. Clin Rev Allergy 1992;10:93-104.
30. Leung D, Cotran R, Kurt-Jones E, Burns J, Newburger J, Pober J. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989;2:1298-302.
31. Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high-dose intravenous immune globulin infusions as the treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000.
32. Mori P, Mancuso G, DelPrincipe D, et al. Chronic idiopathic thrombocytopenia treated with immunoglobulin. Arch Dis Child 1983;58:851-5.
33. Bussel J, Schulman I, Hilgartner M, Barandun S. Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy. J Pediatr 1983;103:654-5.